Primary tabs

A Novel Female-Controlled Antiviral Contraceptive

Renjie Chang of Lavax in the U.S. will develop and test a vaginal suppository that uses a strain of commensal bacteria which has the ability to immobilize sperm and capture viruses. If successful, the bacteria could be used as a reversible contraceptive that also affords protection against viruses such as HIV and herpes.

Grant ID
OPP1025229
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False